LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 28

Search options

  1. Article ; Online: The 2022 ACR/EULAR classification criteria for Takayasu arteritis predict mortality better than the 1990 ACR classification criteria.

    Misra, Durga Prasanna / Rathore, Upendra / Jagtap, Swapnil / Singh, Kritika

    Rheumatology (Oxford, England)

    2024  

    Language English
    Publishing date 2024-03-13
    Publishing country England
    Document type Journal Article
    ZDB-ID 1464822-2
    ISSN 1462-0332 ; 1462-0324
    ISSN (online) 1462-0332
    ISSN 1462-0324
    DOI 10.1093/rheumatology/keae169
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Scalp calcinosis in juvenile dermatomyositis.

    Rathore, Upendra / Gupta, Latika

    Rheumatology (Oxford, England)

    2021  Volume 60, Issue 3, Page(s) 1569

    MeSH term(s) Calcinosis/etiology ; Calcinosis/pathology ; Child ; Dermatomyositis/complications ; Dermatomyositis/pathology ; Humans ; Male ; Scalp/pathology ; Scalp Dermatoses/etiology ; Scalp Dermatoses/pathology
    Language English
    Publishing date 2021-03-04
    Publishing country England
    Document type Case Reports ; Journal Article
    ZDB-ID 1464822-2
    ISSN 1462-0332 ; 1462-0324
    ISSN (online) 1462-0332
    ISSN 1462-0324
    DOI 10.1093/rheumatology/keaa566
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Pleural effusion in Takayasu arteritis: think infection rather than disease activity!

    Misra, Durga Prasanna / Thakare, Darpan R / Rathore, Upendra / Agarwal, Vikas

    Clinical rheumatology

    2023  Volume 42, Issue 6, Page(s) 1719–1720

    MeSH term(s) Humans ; Takayasu Arteritis/complications ; Takayasu Arteritis/diagnosis ; Pleural Effusion/diagnostic imaging ; Pleural Effusion/etiology
    Language English
    Publishing date 2023-02-20
    Publishing country Germany
    Document type Editorial
    ZDB-ID 604755-5
    ISSN 1434-9949 ; 0770-3198
    ISSN (online) 1434-9949
    ISSN 0770-3198
    DOI 10.1007/s10067-023-06551-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Pediatric-onset Takayasu arteritis is associated with greater risk of mortality than adult-onset Takayasu arteritis-A systematic review with meta-analysis of observational cohort studies.

    Rathore, Upendra / Chandwar, Kunal / Singh, Kritika / Misra, Durga Prasanna

    Seminars in arthritis and rheumatism

    2023  Volume 65, Page(s) 152355

    Abstract: A subset of Takayasu arteritis (TAK) has onset in the pediatric age group (≤18 years). The differences in mortality between pediatric-onset and adult-onset TAK are unclear. Therefore, we undertook a systematic review with meta-analysis to compare ... ...

    Abstract A subset of Takayasu arteritis (TAK) has onset in the pediatric age group (≤18 years). The differences in mortality between pediatric-onset and adult-onset TAK are unclear. Therefore, we undertook a systematic review with meta-analysis to compare mortality risk in pediatric-onset with adult-onset TAK. Scopus, Pubmed (MEDLINE and Pubmed Central), recent conference abstracts, clinicaltrials.gov, and the Cochrane database were searched up to August 2023 for relevant studies. Five studies (all of moderate or high quality on the Newcastle Ottawa scale) were identified which had compared mortality between 151 pediatric-onset and 499 adult-onset TAK. Pediatric-onset TAK was associated with a significantly higher risk of death than adult-onset TAK (pooled risk ratio 2.27, 95% confidence interval 1.05 - 4.85, I
    MeSH term(s) Adult ; Humans ; Child ; Adolescent ; Retrospective Studies ; Takayasu Arteritis/complications ; Cohort Studies ; Cardiovascular Diseases/complications ; Prospective Studies ; Observational Studies as Topic
    Language English
    Publishing date 2023-12-22
    Publishing country United States
    Document type Meta-Analysis ; Systematic Review ; Journal Article ; Review
    ZDB-ID 120247-9
    ISSN 1532-866X ; 0049-0172
    ISSN (online) 1532-866X
    ISSN 0049-0172
    DOI 10.1016/j.semarthrit.2023.152355
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Characteristics and outcomes of overlap myositis: a comparative multigroup cohort study in adults from the MyoCite cohort.

    Naveen, R / Rathore, Upendra / Agarwal, Vikas / Gupta, Latika

    Rheumatology international

    2021  Volume 41, Issue 3, Page(s) 551–563

    Abstract: Overlap myositis (OM), an important subset of idiopathic inflammatory myopathies (IIM), is being increasingly recognized with wider myositis-specific autoantibody (MSA) testing. We studied the differences in clinical characteristics and long-term ... ...

    Abstract Overlap myositis (OM), an important subset of idiopathic inflammatory myopathies (IIM), is being increasingly recognized with wider myositis-specific autoantibody (MSA) testing. We studied the differences in clinical characteristics and long-term outcomes of OM with Dermatomyositis (DM), Polymyositis (PM), anti-synthetase syndrome (ASSD), and Cancer-associated IIM (CAM). Data from the MyoCite registry (Dec2017-May2020), a prospective dataset of IIM was extracted for the clinical profile, and MSAs, immunosuppressants received, disease activity (relapses and incomplete response), and treatment-related (drugs ADRs and infections) adverse events (DRAE and TRAE) were collected and analyzed between groups. Of 214 adults (58-OM,89-DM,27-ASSD,33-PM,7-CAM), OM had a greater female preponderance (13.5:1). Raynaud's and sclerodactyly were the prime distinguishing features of OM. OM could be distinguished from PM by frequent arthritis (OR-3.2) and infrequent dysphagia (OR-0.17); DM with greater nephritis (OR-20), infrequent dysphagia (OR-0.24) and rashes (OR-0.02); and ASSD by infrequent ILD (OR-0.07), and mechanic's hand (OR-0.05). 50% fulfilled the classification criteria for ASSD in the absence of MSA testing. ANA was positive more often (PM/DM: OR-6.7) and anti-Ro52 (OR-4.5) frequent in OM. Baseline serum creatinine and acute phase reactants were higher. OM received lower glucocorticoids (0 mg/kg, p < 0.001). Overall, 90% and 84% of OM at 12 and 24 months, respectively, achieved remission, with similar DRAE and TRAE as other IIM subsets. OM can be misdiagnosed as ASSD in the absence of MSA testing. Raynaud's, sclerodactyly, and a positive ANA may identify OM and prevent overtreatment.
    MeSH term(s) Adult ; Antibodies, Antinuclear/blood ; Cohort Studies ; Databases, Factual ; Female ; Glucocorticoids/therapeutic use ; Humans ; Immunosuppressive Agents/therapeutic use ; India ; Male ; Middle Aged ; Myositis/complications ; Myositis/drug therapy ; Myositis/immunology ; Myositis/physiopathology ; Raynaud Disease/etiology ; Scleroderma, Systemic/etiology ; Syndrome
    Chemical Substances Antibodies, Antinuclear ; Glucocorticoids ; Immunosuppressive Agents
    Language English
    Publishing date 2021-01-10
    Publishing country Germany
    Document type Journal Article ; Multicenter Study
    ZDB-ID 8286-7
    ISSN 1437-160X ; 0172-8172
    ISSN (online) 1437-160X
    ISSN 0172-8172
    DOI 10.1007/s00296-020-04779-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Presentation and clinical course of pediatric-onset versus adult-onset Takayasu arteritis—a systematic review and meta-analysis

    Misra, Durga Prasanna / Rathore, Upendra / Kopp, Chirag Rajkumar / Patro, Pallavi / Agarwal, Vikas / Sharma, Aman

    Clin Rheumatol 2022 Dec., v. 41, no. 12, p. 3601-3613

    2022  , Page(s) 3601–3613

    Abstract: Takayasu arteritis (TAK) is a less common large-vessel vasculitis which can occur in either children or adults. However, differences between pediatric-onset and adult-onset TAK have not been systematically analyzed. We undertook a systematic review (pre- ... ...

    Abstract Takayasu arteritis (TAK) is a less common large-vessel vasculitis which can occur in either children or adults. However, differences between pediatric-onset and adult-onset TAK have not been systematically analyzed. We undertook a systematic review (pre-registered on PROSPERO, identifier CRD42022300238) to analyze differences in clinical presentation, angiographic involvement, treatments, and outcomes between pediatric-onset and adult-onset TAK. We searched PubMed (MEDLINE and PubMed Central), Scopus, major recent international rheumatology conference abstracts, Cochrane database, and clinicaltrials.gov, and identified seven studies of moderate to high quality comparing pediatric-onset and adult-onset TAK. Meta-analysis of 263 pediatric-onset and 981 adult-onset TAK suggested that constitutional features (fever, and in subgroup analyses, weight loss), hypertension, headache, and sinister features of cardiomyopathy, elevated serum creatinine, and abdominal pain were more frequent in pediatric-onset TAK, whereas pulse loss/pulse deficit and claudication (particularly upper limb claudication) were more frequent in adult-onset TAK. Hata’s type IV TAK was more common in pediatric-onset TAK, and Hata’s type I TAK in adult-onset TAK. Children with TAK also appeared to require more intense immunosuppression with more frequent use of cyclophosphamide, biologic DMARDs, tumor necrosis factor alpha inhibitors, and, in subgroup analyses, tocilizumab in pediatric-onset TAK than in adult-onset TAK. Surgical or endovascular procedures, remission, and risk of mortality were similar in both children and adults with TAK. No studies had compared patient-reported outcome measures between pediatric-onset and adult-onset TAK. Distinct clinical features and angiographic extent prevail between pediatric-onset and adult-onset TAK. Clinical outcomes in these subgroups require further study in multicentric cohorts.
    Keywords angiography ; arteritis ; blood serum ; cardiomyopathy ; creatinine ; cyclophosphamide ; databases ; fever ; headache ; hypertension ; immunosuppression ; meta-analysis ; mortality ; remission ; risk ; systematic review ; tumor necrosis factor-alpha ; vasculitis ; weight loss
    Language English
    Dates of publication 2022-12
    Size p. 3601-3613
    Publishing place Springer International Publishing
    Document type Article ; Online
    Note Review
    ZDB-ID 604755-5
    ISSN 0770-3198
    ISSN 0770-3198
    DOI 10.1007/s10067-022-06318-5
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  7. Article ; Online: Psoriasiform rashes as the first manifestation of anti-MDA5 associated myositis.

    Rathore, Upendra / Haldule, Saloni / Gupta, Latika

    Rheumatology (Oxford, England)

    2020  Volume 60, Issue 7, Page(s) 3483

    MeSH term(s) Arthritis/immunology ; Arthritis/physiopathology ; Autoantibodies/immunology ; Dermatomyositis/immunology ; Dermatomyositis/pathology ; Dermatomyositis/physiopathology ; Ear Auricle/pathology ; Exanthema/pathology ; Facial Dermatoses/pathology ; Fever/physiopathology ; Humans ; Interferon-Induced Helicase, IFIH1/immunology ; Male ; Muscle Weakness/immunology ; Muscle Weakness/physiopathology ; Myositis/immunology ; Myositis/pathology ; Myositis/physiopathology ; Scalp Dermatoses/pathology ; Young Adult
    Chemical Substances Autoantibodies ; IFIH1 protein, human (EC 3.6.1.-) ; Interferon-Induced Helicase, IFIH1 (EC 3.6.4.13)
    Language English
    Publishing date 2020-12-18
    Publishing country England
    Document type Case Reports ; Journal Article
    ZDB-ID 1464822-2
    ISSN 1462-0332 ; 1462-0324
    ISSN (online) 1462-0332
    ISSN 1462-0324
    DOI 10.1093/rheumatology/keaa821
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Presentation and clinical course of pediatric-onset versus adult-onset Takayasu arteritis-a systematic review and meta-analysis.

    Misra, Durga Prasanna / Rathore, Upendra / Kopp, Chirag Rajkumar / Patro, Pallavi / Agarwal, Vikas / Sharma, Aman

    Clinical rheumatology

    2022  Volume 41, Issue 12, Page(s) 3601–3613

    Abstract: Takayasu arteritis (TAK) is a less common large-vessel vasculitis which can occur in either children or adults. However, differences between pediatric-onset and adult-onset TAK have not been systematically analyzed. We undertook a systematic review (pre- ... ...

    Abstract Takayasu arteritis (TAK) is a less common large-vessel vasculitis which can occur in either children or adults. However, differences between pediatric-onset and adult-onset TAK have not been systematically analyzed. We undertook a systematic review (pre-registered on PROSPERO, identifier CRD42022300238) to analyze differences in clinical presentation, angiographic involvement, treatments, and outcomes between pediatric-onset and adult-onset TAK. We searched PubMed (MEDLINE and PubMed Central), Scopus, major recent international rheumatology conference abstracts, Cochrane database, and clinicaltrials.gov, and identified seven studies of moderate to high quality comparing pediatric-onset and adult-onset TAK. Meta-analysis of 263 pediatric-onset and 981 adult-onset TAK suggested that constitutional features (fever, and in subgroup analyses, weight loss), hypertension, headache, and sinister features of cardiomyopathy, elevated serum creatinine, and abdominal pain were more frequent in pediatric-onset TAK, whereas pulse loss/pulse deficit and claudication (particularly upper limb claudication) were more frequent in adult-onset TAK. Hata's type IV TAK was more common in pediatric-onset TAK, and Hata's type I TAK in adult-onset TAK. Children with TAK also appeared to require more intense immunosuppression with more frequent use of cyclophosphamide, biologic DMARDs, tumor necrosis factor alpha inhibitors, and, in subgroup analyses, tocilizumab in pediatric-onset TAK than in adult-onset TAK. Surgical or endovascular procedures, remission, and risk of mortality were similar in both children and adults with TAK. No studies had compared patient-reported outcome measures between pediatric-onset and adult-onset TAK. Distinct clinical features and angiographic extent prevail between pediatric-onset and adult-onset TAK. Clinical outcomes in these subgroups require further study in multicentric cohorts.
    MeSH term(s) Child ; Adult ; Humans ; Takayasu Arteritis/therapy ; Takayasu Arteritis/drug therapy ; Retrospective Studies ; Cyclophosphamide/therapeutic use ; Immunosuppression Therapy ; Antirheumatic Agents/therapeutic use
    Chemical Substances Cyclophosphamide (8N3DW7272P) ; Antirheumatic Agents
    Language English
    Publishing date 2022-08-05
    Publishing country Germany
    Document type Meta-Analysis ; Systematic Review ; Journal Article ; Review
    ZDB-ID 604755-5
    ISSN 1434-9949 ; 0770-3198
    ISSN (online) 1434-9949
    ISSN 0770-3198
    DOI 10.1007/s10067-022-06318-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Prevalent Drug Usage Practices in Adults and Children With Idiopathic Inflammatory Myopathies: Registry-Based Analysis From the MyoCite Cohort.

    Mehta, Pankti / Rathore, Upendra / Naveen, R / Chatterjee, Rudrarpan / Agarwal, Vikas / Aggarwal, Rohit / Gupta, Latika

    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases

    2022  Volume 28, Issue 2, Page(s) 89–96

    Abstract: Background: Idiopathic inflammatory myopathies (IIMs) form a heterogeneous group of disorders with a deficit of quality evidence regarding its management. Therefore, we aimed to explore the prevalent treatment practices in the MyoCite cohort from India.! ...

    Abstract Background: Idiopathic inflammatory myopathies (IIMs) form a heterogeneous group of disorders with a deficit of quality evidence regarding its management. Therefore, we aimed to explore the prevalent treatment practices in the MyoCite cohort from India.
    Methods: Drug usage patterns, their predictors, drug retention rates, efficacy, and adverse drug reactions were analyzed for adults and children newly diagnosed with IIM (2017-2020) and followed prospectively and compared with real-world data by performing a medical records review. GraphPad Prism version 8.4.2 was used for statistical analysis.
    Results: Of 181 adults (male-to-female ratio, 1:4.6) and 30 children (M:F, 1.3:1), dermatomyositis (41% adults, 93% children) was the most common subtype. Methotrexate (MTX) was the drug of choice (67% adult, 90% children) followed by azathioprine (AZA) and mycophenolate mofetil (MMF). The MMF, AZA, cyclophosphamide, and rituximab (RTX) were preferred for those with antisynthetase syndrome (ASSD) and those with lung involvement, whereas MTX was avoided in them. Functional class and family income did not determine drug preferences. Glucocorticoids were initiated at a lower dose in overlap myositis (45% vs 80%, p = 0.001), and the time to achieve the lowest dose of glucocorticoids was longer than 24 months for ASSD (77% vs 14%, p = 0.002).Over a median of 35 months, the overall retention rate was the highest for RTX (75%) followed by MTX (58%). Relapse-free survival was the highest for RTX followed by MTX. The most common reasons for discontinuation were adverse drug reactions for MTX and MMF, inefficacy for AZA, and cost for RTX.
    Conclusions: In this first analysis of drug usage and retention in patients with IIM in Northern India, MTX emerged as the most preferred drug in both adults and children, with the exception of those with ASSD or lung disease. Organ involvement and subtype of IIM are key determinants of drug preference. Overall, RTX and MTX were well-tolerated with high retention rates, followed by AZA and MMF.
    MeSH term(s) Adult ; Azathioprine/therapeutic use ; Child ; Female ; Humans ; Immunosuppressive Agents/adverse effects ; Male ; Mycophenolic Acid/therapeutic use ; Myositis/diagnosis ; Myositis/drug therapy ; Myositis/epidemiology ; Pharmaceutical Preparations ; Registries ; Treatment Outcome
    Chemical Substances Immunosuppressive Agents ; Pharmaceutical Preparations ; Mycophenolic Acid (HU9DX48N0T) ; Azathioprine (MRK240IY2L)
    Language English
    Publishing date 2022-01-19
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1283266-2
    ISSN 1536-7355 ; 1076-1608
    ISSN (online) 1536-7355
    ISSN 1076-1608
    DOI 10.1097/RHU.0000000000001813
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Renal involvement in Sjőgren's syndrome: predictors and impact on patient outcomes.

    Chatterjee, Rudrarpan / Balakrishnan, Anu / Kharbanda, Rajat / Rathore, Upendra / Gupta, Latika / Misra, Durga P / Agarwal, Vikas / Aggarwal, Amita / Lawrence, Able

    Rheumatology international

    2023  Volume 43, Issue 7, Page(s) 1297–1306

    Abstract: Renal disease in primary Sjogren's Syndrome(pSS) occurs as tubulointerstitial nephritis(TIN) or glomerulonephritis(GN). Data from India on pSS are sparse and even less on nephritis.We studied the prevalence and impact of renal disease on patient outcomes. ...

    Abstract Renal disease in primary Sjogren's Syndrome(pSS) occurs as tubulointerstitial nephritis(TIN) or glomerulonephritis(GN). Data from India on pSS are sparse and even less on nephritis.We studied the prevalence and impact of renal disease on patient outcomes. We reviewed 179 (F:M 12.7:1, age 41.7 ± 12.9 years) patients of pSS from records at a single centre from 2000 to 2020. Data on nephritis, clinical and laboratory variables were collected from baseline visit. Outcomes studied were chronic kidney disease(CKD) and death. We identified predictors of nephritis and rising creatinine on follow-up.Fifty-four (30.17%) patients had nephritis. Their mean age was 40.19 ± 13.28 years with 157.3 person-years follow-up. Vasculitis (OR 2.33, 1.02-5.3), fatigue (OR 3.29, 1.63-6.65), ANA positivity (OR 7.79, 1-60.62), anti-Ro52 (OR 2.74, 1.18-6.39), anti-La (OR 2.13, 1.1-4.14), both Ro and La (OR 2.4, 1.23-4.69) and lymphopenia (OR 2.27, 1.16-4.41) predicted nephritis on univariate analysis. On multivariate analysis, only fatigue (OR 2.83, 1.22-6.57) and an interaction between polyarthritis and vasculitis (OR 9.17, 1.15-72.96) was associated with nephritis. Creatinine at one (1.6 ± 1.17 mg/dL vs. 0.8 ± 0.2 mg/dL) and 2 years (1.62 ± 1.19 mg/dL vs. 0.8 ± 0.2 mg/dL) follow-up was higher in the nephritis group. Baseline haematuria, leukocyturia, 24 h urinary protein and thrombocytopenia were independent predictors of rising creatinine. Six patients died and 10 developed CKD. Event-free (death or CKD) survival was 89.1% at 5 years. Patients with nephritis had worse event-free survival.Our cohort had a younger age of onset of Sjogren's syndrome and a higher prevalence of nephritis than previously reported. Fatigue, polyarthritis and vasculitis at baseline predicted the development of nephritis. Nephritis was associated with a higher probability of death or CKD.
    MeSH term(s) Humans ; Adult ; Middle Aged ; Sjogren's Syndrome/complications ; Sjogren's Syndrome/epidemiology ; Creatinine ; Nephritis, Interstitial/epidemiology ; Arthritis/complications ; Renal Insufficiency, Chronic/diagnosis ; Renal Insufficiency, Chronic/epidemiology ; Renal Insufficiency, Chronic/complications ; Vasculitis/complications
    Chemical Substances Creatinine (AYI8EX34EU)
    Language English
    Publishing date 2023-01-18
    Publishing country Germany
    Document type Review ; Journal Article
    ZDB-ID 8286-7
    ISSN 1437-160X ; 0172-8172
    ISSN (online) 1437-160X
    ISSN 0172-8172
    DOI 10.1007/s00296-022-05242-w
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top